Showing results (781-790 of 2,132) with videos related to
Sort By:
Pageof 214
Biopharmaceutics & Drug Disposition|October 1, 1982
Personality traits and theophylline metabolismA G Hartzema, S Pancorbo, S DavisBiopharmaceutics & Drug Disposition|January 1, 1981
Bioavailability of sustained release propranolol formulationsJ McAinsh, N S Baber, B F Holmes, et al.Biopharmaceutics & Drug Disposition|May 5, 2020
Deoxyshikonin reversibly inhibits cytochrome P450 2B6Ju-Hyun Kim, Su Min Choi, Riya Shreatha, et al.Biopharmaceutics & Drug Disposition|November 1, 1989
Effects of obesity and ancillary variables (dialysis time, drug, albumin, and fatty acid concentrations) on theophylline serum protein bindingL Shum, W J JuskoBiopharmaceutics & Drug Disposition|November 1, 1989
Absorption kinetics of cyclosporine in healthy volunteersS K Gupta, L Z BenetBiopharmaceutics & Drug Disposition|July 2, 2015
Metabolism of (-)-cis- and (-)-trans-rose oxide by cytochrome P450 enzymes in human liver microsomesHiroshi Nakahashi, Yuuki Yamamura, Atsushi Usami, et al.Biopharmaceutics & Drug Disposition|June 26, 2015
Identification and disposition of novel mono-hydroxyl mefenamic acid and their potentially toxic 1-O-acyl-glucuronides in vivoSophia Yui Kau Fong, Yufeng Zhang, Yin Cheong Wong, et al.Biopharmaceutics & Drug Disposition|October 23, 1997
Pharmacokinetic analysis and antiepileptic activity of two new isomers of N-valproyl glycinamideS Hadad, M BialerBiopharmaceutics & Drug Disposition|July 1, 1982
The single-point method of dosage prediction: pharmacokinetic basis and method optimizationB L Love, S E Tsuei, J Thomas, et al.Biopharmaceutics & Drug Disposition|July 1, 1982
Comparative bioavailability of S-carboxymethylcysteine from two dosage forms: hard gelatin capsule and syrupJ M Aiache, J P Borel, J P KantelipPageof 214